Bank of New York Mellon’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44.6M | Sell |
808,139
-129,449
| -14% | -$7.01M | 0.01% | 1059 |
|
|
2025
Q4 | $46M | Sell |
937,588
-92,613
| -9% | -$4.32M | 0.01% | 1056 |
|
|
2025
Q3 | $44.5M | Buy |
1,030,201
+40,329
| +4% | +$1.58M | 0.01% | 1100 |
|
|
2025
Q2 | $38M | Sell |
989,872
-61,765
| -6% | -$2.36M | 0.01% | 1163 |
|
|
2025
Q1 | $40.7M | Buy |
1,051,637
+77,586
| +8% | +$2.84M | 0.01% | 1085 |
|
|
2024
Q4 | $32.9M | Buy |
974,051
+20,659
| +2% | +$744K | 0.01% | 1277 |
|
|
2024
Q3 | $39M | Buy |
953,392
+26,875
| +3% | +$1.1M | 0.01% | 1188 |
|
|
2024
Q2 | $35.7M | Buy |
926,517
+69,649
| +8% | +$2.93M | 0.01% | 1228 |
|
|
2024
Q1 | $36.7M | Sell |
856,868
-39,549
| -4% | -$1.63M | 0.01% | 1226 |
|
|
2023
Q4 | $33.2M | Sell |
896,417
-41,272
| -4% | -$1.48M | 0.01% | 1311 |
|
|
2023
Q3 | $34M | Sell |
937,689
-13,966
| -1% | -$496K | 0.01% | 1227 |
|
|
2023
Q2 | $33.9M | Sell |
951,655
-46,074
| -5% | -$1.65M | 0.01% | 1241 |
|
|
2023
Q1 | $35.5M | Sell |
997,729
-37,293
| -4% | -$1.3M | 0.01% | 1214 |
|
|
2022
Q4 | $36.4M | Buy |
1,035,022
+3,424
| +0.3% | +$114K | 0.01% | 1190 |
|
|
2022
Q3 | $30.4M | Buy |
1,031,598
+89,437
| +9% | +$3.39M | 0.01% | 1247 |
|
|
2022
Q2 | $51.3M | Buy |
942,161
+13,216
| +1% | +$730K | 0.01% | 971 |
|
|
2022
Q1 | $50.6M | Sell |
928,945
-87,625
| -9% | -$4.76M | 0.01% | 1088 |
|
|
2021
Q4 | $56M | Sell |
1,016,570
-203,834
| -17% | -$10.6M | 0.01% | 1074 |
|
|
2021
Q3 | $58.3M | Buy |
1,220,404
+253,542
| +26% | +$12.7M | 0.01% | 1033 |
|
|
2021
Q2 | $48.1M | Sell |
966,862
-16,420
| -2% | -$789K | 0.01% | 1161 |
|
|
2021
Q1 | $43.9M | Sell |
983,282
-52,227
| -5% | -$2.37M | 0.01% | 1200 |
|
|
2020
Q4 | $47.6M | Sell |
1,035,509
-141,928
| -12% | -$6.52M | 0.01% | 1071 |
|
|
2020
Q3 | $55.4M | Sell |
1,177,437
-40,324
| -3% | -$2.02M | 0.01% | 859 |
|
|
2020
Q2 | $62.1M | Sell |
1,217,761
-189,919
| -13% | -$9.74M | 0.02% | 763 |
|
|
2020
Q1 | $66.7M | Sell |
1,407,680
-303,562
| -18% | -$16.2M | 0.02% | 630 |
|
|
2019
Q4 | $101M | Buy |
1,711,242
+2,471
| +0.1% | +$137K | 0.03% | 606 |
|
|
2019
Q3 | $91.2M | Buy |
1,708,771
+25,321
| +2% | +$1.3M | 0.03% | 626 |
|
|
2019
Q2 | $84.2M | Sell |
1,683,450
-55,628
| -3% | -$2.79M | 0.02% | 674 |
|
|
2019
Q1 | $90.8M | Sell |
1,739,078
-87,542
| -5% | -$4.37M | 0.03% | 632 |
|
|
2018
Q4 | $87.2M | Sell |
1,826,620
-18,253
| -1% | -$899K | 0.03% | 577 |
|
|
2018
Q3 | $92.6M | Sell |
1,844,873
-3,032,165
| -62% | -$154M | 0.02% | 654 |
|
|
2018
Q2 | $246M | Buy |
4,877,038
+315,141
| +7% | +$15.9M | 0.07% | 287 |
|
|
2018
Q1 | $223M | Sell |
4,561,897
-32,274
| -0.7% | -$1.5M | 0.06% | 319 |
|
|
2017
Q4 | $204M | Sell |
4,594,171
-77,217
| -2% | -$3.57M | 0.05% | 363 |
|
|
2017
Q3 | $237M | Sell |
4,671,388
-16,882
| -0.4% | -$856K | 0.07% | 319 |
|
|
2017
Q2 | $253M | Sell |
4,688,270
-43,718
| -0.9% | -$2.33M | 0.07% | 281 |
|
|
2017
Q1 | $249M | Sell |
4,731,988
-73,822
| -2% | -$3.74M | 0.07% | 296 |
|
|
2016
Q4 | $231M | Sell |
4,805,810
-44,561
| -0.9% | -$2.2M | 0.07% | 308 |
|
|
2016
Q3 | $261M | Buy |
4,850,371
+69,021
| +1% | +$3.78M | 0.08% | 274 |
|
|
2016
Q2 | $259M | Buy |
4,781,350
+28,631
| +0.6% | +$1.51M | 0.08% | 265 |
|
|
2016
Q1 | $241M | Sell |
4,752,719
-155,699
| -3% | -$7.75M | 0.07% | 278 |
|
|
2015
Q4 | $248M | Sell |
4,908,418
-75,370
| -2% | -$3.84M | 0.07% | 276 |
|
|
2015
Q3 | $240M | Buy |
4,983,788
+32,452
| +0.7% | +$1.69M | 0.07% | 285 |
|
|
2015
Q2 | $258M | Sell |
4,951,336
-36,638
| -0.7% | -$2.06M | 0.07% | 300 |
|
|
2015
Q1 | $288M | Sell |
4,987,974
-19,998
| -0.4% | -$1.15M | 0.07% | 299 |
|
|
2014
Q4 | $268M | Sell |
5,007,972
-112,691
| -2% | -$6.3M | 0.07% | 302 |
|
|
2014
Q3 | $294M | Sell |
5,120,663
-201,324
| -4% | -$12.3M | 0.08% | 264 |
|
|
2014
Q2 | $356M | Sell |
5,321,987
-131,549
| -2% | -$8.9M | 0.1% | 227 |
|
|
2014
Q1 | $364M | Sell |
5,453,536
-36,214
| -0.7% | -$2.45M | 0.1% | 212 |
|
|
2013
Q4 | $366M | Sell |
5,489,750
-1,240,120
| -18% | -$80.4M | 0.1% | 210 |
|
|
2013
Q3 | $422M | Sell |
6,729,870
-604,720
| -8% | -$38.9M | 0.13% | 167 |
|
|
2013
Q2 | $458M | Buy |
+7,334,590
| New | +$466M | 0.14% | 134 |
|
Other funds holding GSK
JEST
